Your browser doesn't support javascript.
loading
Adverse event reports of anaphylaxis after Comirnaty and Vaxzevria COVID-19 vaccinations, Western Australia, 22 February to 30 June 2021.
Shivarev, Alexander; Phillips, Anastasia; Brophy-Williams, Sam; Ford, Tim; Richmond, Peter; Effler, Paul; McLean-Tooke, Andrew.
Afiliação
  • Shivarev A; Department of Clinical Immunology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.
  • Phillips A; Metropolitan Communicable Disease Control, North Metropolitan Health Service, Perth, Western Australia, Australia.
  • Brophy-Williams S; Metropolitan Communicable Disease Control, North Metropolitan Health Service, Perth, Western Australia, Australia.
  • Ford T; Western Australian Vaccine Safety Surveillance and Department of Infectious Diseases, Perth Children's Hospital, Perth, Western Australia, Australia.
  • Richmond P; Western Australian Vaccine Safety Surveillance and Department of Infectious Diseases, Perth Children's Hospital, Perth, Western Australia, Australia.
  • Effler P; Discipline of Paediatrics, Medical School, The University of Western Australia, Perth, Western Australia, Australia.
  • McLean-Tooke A; Discipline of Paediatrics, Medical School, The University of Western Australia, Perth, Western Australia, Australia.
Intern Med J ; 53(2): 275-279, 2023 02.
Article em En | MEDLINE | ID: mdl-36585764

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 / Anafilaxia Limite: Humans País/Região como assunto: Oceania Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 / Anafilaxia Limite: Humans País/Região como assunto: Oceania Idioma: En Ano de publicação: 2023 Tipo de documento: Article